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Undifferentiated nasopharyngeal carcinomas (NPCs) are commonly
present with latent EBV infection. However, events regulating EBV
infection at early stages of the disease and the role of EBV in disease
pathogenesis are largely undefined. Genetic alterations leading to
activation of cyclin D1 signaling in premalignant nasopharyngeal
epithelial (NPE) cells have been postulated to predispose cells to
EBV infection. We previously reported that loss of p16, a negative
regulator of cyclin D1 signaling, is a frequent feature of NPC tumors.
Here, we report that early premalignant lesions of nasopharyngeal
epithelium overexpress cyclin D1. Furthermore, overexpression of
cyclin D1 is closely associated with EBV infection. Therefore we in-
vestigated the potential role of cyclin D1overexpression in dysplastic
NPE cells in vitro. In human telomerase reverse transcriptase-immor-
talized NPE cells, overexpression of cyclin D1 or a p16-resistant form
ofCDK4 (CDK4R24C) suppressed differentiation. This suppressionmay
have implications for the close association of EBV infection with un-
differentiated NPC. In these in vitro models, we found that cellular
growth arrest and senescence occurred in EBV-infected cell popula-
tions immediately after infection. Nevertheless, overexpression of
cyclin D1 or a p16-resistant form of CDK4 or knockdown of p16 in
the human telomerase reverse transcriptase-immortalized NPE cell
lines could counteract the EBV-induced growth arrest and senes-
cence. We conclude that dysregulated expression of cyclin D1 in
NPE cells may contribute to NPC pathogenesis by enabling persistent
infection of EBV.
Epstein-Barr virus | episome | viral persistence
EBV infection is detected in nearly all undifferentiated or poorlydifferentiated nasopharyngeal carcinoma (NPC) in endemic
regions, such as southern China, including Hong Kong (1). Es-
tablishment of persistent infection in nasopharyngeal epithelial
(NPE) cells is believed to be an early and essential step for NPC
development (2, 3). However, events regulating EBV infection in
premalignant NPE cells are largely undefined.
Although EBV infection in normal nasopharyngeal epithelium is
uncommon, latent EBV infection could be detected ubiquitously in
preinvasive lesions and is believed to play a crucial role in NPC
pathogenesis (4). The detection of a single clonal EBV genome in
these preinvasive lesions and NPC indicated that NPC pathogen-
esis involves clonal expansion of a single EBV-infected NPE cell (3,
4). EBVmay be able to infect cells in premalignant nasopharyngeal
epithelium, but it is likely that only specific clones with permissive
cellular content can support long-term propagation of EBV. The
current hypothesis is that genetic alterations or dysregulated cell-
signaling pathways in premalignant NPE cells render them per-
missive for EBV persistence and malignant transformation (3, 5–
7). We have established several primary and human telomerase
reverse transcriptase (hTert)-immortalized cell lines to serve as cell
models for EBV infection study (8). None of these cells was able to
support stable EBV infection in prolonged culture, except for
NP460hTert, which harbors a p16 deletion (8). We reported
previously that allelic deletion of chromosome 9p (involving the
loci of p16INK4A) is a common feature of NPC and can be
detected in the rare, low-grade dysplastic lesions of nasopha-
ryngeal epithelium before EBV infection (5, 9). Furthermore,
using high-resolution comparative genomic hybridization arrays,
we mapped the gain of a 5.3-Mb amplicon including the cyclin
D1 locus in chromosome 11q13.1 in NPC (10). Concordant
amplification and/or overexpression of cyclin D1 is a common
event in primary NPC and was detected in 35 of 38 primary NPC
biopsies (92%). Deletion of p16 and overexpression of cyclin D1
lead to dysregulation and activation of the cyclin D1 signaling
pathway, respectively. However, it remains to be determined
if these genetic alterations predispose NPE cells to persistent EBV
infection.
Cyclin D1 is a key cell-cycle regulatory protein promoting G1/S
transition in cells (11). It complexes with CDK4 or CDK6 to
phosphorylate the retinoblastoma tumor suppressor protein,
resulting in the release of the E2F transcription factor to promote
cell-cycle progression (12). More importantly, ectopic expression
of cyclin D1 has been shown to drive cell-cycle progression and
to suppress terminal differentiation in several cellular systems,
including keratinocytes, myotubes, adipocytes, and nerve cells
(11, 13). An earlier in vitro study indicated that undifferentiated
cells may be more permissive for latent EBV infection by sup-
porting expression of EBNA1 (14). All these observations have
implications for the close association of EBV infection with
undifferentiated but not differentiated NPC.
We postulated that cyclin D1 may be involved directly in pro-
moting cell-cycle progression and suppression of terminal dif-
ferentiation of NPE cells, thus conferring a permissive cellular
environment for persistent EBV infection and its propagation in
NPE cells. In this study, we provide experimental evidence to
support these roles of cyclin D1 in facilitating stable and latent
EBV infection in premalignant NPE cells.
Results
Overexpression of Cyclin D1 is Common in EBV-Infected Dysplastic
NPE Tissues. We previously reported that overexpression of cyclin
D1 is a common event in NPC and can be detected in more than
90% of NPC specimens examined (35 of 38 cases) (10). To
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examine if aberrant expression of cyclin D1 is associated with EBV
infection at early stage of disease development, expression of
cyclin D1 and EBV-encoded RNA (EBER) was examined in
consecutive histopathological sections of six rare archival speci-
mens of dysplastic NPE tissues by immunohistochemistry and
by in situ hybridization. Overexpression of cyclin D1 could be
detected in all of the six cases examined. Overexpression of
cyclin D1 coexisted with positive EBER staining in the epithe-
lium of these dysplastic NPE tissues, supporting a close link
between cyclin D1 overexpression and EBV infection in the
early stage of NPC development (Fig. 1). In contrast, cyclin D1
was detected only in basal and suprabasal cell layers of the
EBER-negative normal nasopharyngeal epithelium. Interestingly,
LMP1 was expressed in one of the six dysplastic NPE tissues
examined (Fig. 1). In our experience, LMP1 is rarely detected
by immunocytochemistry in preneoplastic NPE tissues. The role
of LMP1 in the early stage of NPC development remains to
be determined.
Overexpression of Cyclin D1 Conferred Resistance to Serum-Induced
Differentiation in hTert-Immortalized NPE Cells. EBV infection is
closely associated with the histologically undifferentiated type of
NPC. Overexpression of cyclin D1 is known to suppress cellular
differentiation and can be detected readily in dysplastic NPE
tissues (Fig. 1). We investigated a potential role of cyclin D1
overexpression or activation of the cyclin D1/CDK4 pathway in
contributing to the undifferentiated property of dysplastic NPE
cells using hTert-immortalized NPE cell lines derived from
nonmalignant nasopharyngeal tissues (8). All these immortalized
NPE cell lines have been propagated in serum-free medium for
more than 100 passages and show no sign of growth cessation or
differentiation. Serum is a potent agent commonly used to in-
duce terminal differentiation in culturing epithelial cells. To
examine if activation of the cyclin D1 pathway might influence
the ability of NPE cells to resist differentiation, we overexpressed
either cyclin D1 or a CDK4 mutant (CDKR24C) in these im-
mortalized NPE cell lines and examined their responses toward
serum-induced differentiation. CDK4R24C is a dominantly active
mutant of CDK4 insensitive to its inhibitor, p16. Overexpression
of CDK4R24C resulted in constitutive activation of the cyclin D1/
CDK4 complex in immortalized NPE cells. Although treatment
with 10% (vol/vol) FBS effectively induced growth arrest in all
the control hTert-immortalized NPE cell lines, cells over-
expressing cyclin D1 or CDK4R24C were resistant to it (Fig. 2A).
NPE cells overexpressing cyclin D1 or CDK4R24C continued to
proliferate in the presence of serum (Fig. 2A). Furthermore,
a terminally differentiated phenotype with enlarged and flattened
cell morphology and with prominent intracellular keratin net-
works was observed in control NP550hTert or NP361Tert cells
after treatment with serum but not after transduction of cyclin D1
or CDK4R24C (Fig. S1). In addition, the expression of involucrin,
a marker for the terminal differentiation of squamous epithe-
lium, was detected after FBS treatment in control NP550hTert
cells but not in cells overexpressing cyclin D (Fig. 2B). A role for
cyclin D1 overexpression and activation of the cyclin D1/CDK4
pathway in resisting differentiation in immortalized NPE cells was
confirmed further by Western blots showing up-regulated ex-
pression of involucrin in the control immortalized NPE cells after
FBS treatment but not in NPE cells overexpressing cyclin D1/
CDK4R24C (Fig. 2C).
Activation of the Cyclin D1 Pathway Supports Clonal Proliferation of
EBV-infected Cells. Next, we examined whether activation of the
cyclin D1 pathway could support persistent EBV infection in
hTert-immortalized cells (NP550hTert and NP361hTert). Over-
expression of cyclin D1 and CDK4R24C and p16 silencing were
achieved in NP550hTert or NP361hTert cells (Fig. 3A). We then
subjected these NPE cells to EBV infection using a previously
published protocol (8). The immortalized NPE cells were plated
at a low cell density after EBV infection to observe the appear-
ance of proliferative EBV-infected (GFP+) colonies. In our pre-
vious study, we had seen that the ability of EBV-infected NPE
cells to form proliferative colonies is a reliable indication of
stable EBV infection in NPE cells (8). Proliferative EBV-infected
(GFP+) colonies were readily observed in hTert-immortalized
cells after cyclin D1 or CDK4R24C transducation or p16 silencing,
but not in the respective control cells (Fig. 3A). These results
suggest that activation of the cyclin D1/CDK4 pathway supports
stable EBV infection in NPE cells. Moreover, susceptibility to EBV
infection was not altered significantly in NPE cells overexpressing
cyclin D1 and CDK R24C or by knockdown of p16 (Fig. S2), sug-
gesting that the mechanism for supporting stable EBV infection
is dependent more on cellular content than on an enhanced rate
of infection.
We have established additional immortalized NPE cells using
various defined genetic components. When examined for their
ability to support EBV infection, only NPE cells immortalized by
hTert in combination with either cyclin D1 or CDK4R24C were
able to support stable EBV infection. Proliferative EBV-infected
clones were readily observed in these cells but not in control
NPE cells immortalized by hTert alone (Fig. 3B and Table 1).
The ectopic expression of cyclin D1 and CDK4R24C in these cells
also was confirmed by Western blotting analysis (Fig. S3). Cyclin
D1 and CDK4R24C levels were two- or threefold higher in the
HA-cyclin D1/CDK4R24C transfectants. Apparently, these in-
cremental levels of cyclin D1 and CDK4R24C are sufficient to
support clonal proliferation of EBV-infected NPE cells. These
observations provide further evidence supporting the hypothesis
Normal nasopharyngeal epithelia Invasive tumor 
H&E EBER LMP1 Cyclin D1
Case 1
Case 2
Case 3
Dysplastic nasopharyngeal epithelial tissues
EBERCyclin D1 EBERCyclin D1
Case 1
Case 2
Fig. 1. Overexpression of cyclin D1 and EBV infection in dysplastic naso-
pharyngeal epithelium. (Upper) Representative images of H&E staining,
EBER in situ hybridization, and immunohistochemical staining of cyclin D1
and LMP1 performed in consecutive sections of three specimens of dysplastic
NPE tissue. In the first column from the left, H&E staining revealed a dys-
plastic epithelium. In the second column, the dysplastic epithelial cells were
EBER+ by in situ hybridization. In the third column, LMP1 expression (red
arrow) was detected in one of the six dysplastic nasopharyngeal lesions. In
the fourth column, overexpression of cyclin D1 was detected in dysplastic
epithelium. (Lower) Images of two cases of normal epithelium and one in-
vasive NPC tissue. (Left) Expression of cyclin D1 was detected in the basal and
suprabasal layers in normal and EBER− nasopharyngeal epithelium. (Right)
Overexpression of cyclin D1 in EBER+ NPC.
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that activation of the cyclin D1/CDK4 signaling pathway enables
stable EBV infection in immortalized NPE cells.
EBV-Infection Induced Growth Inhibition and Senescence in NPE Cells
Immortalized by hTert Alone. We then investigated the underlying
cause prohibiting stable EBV infection in NP550hTert and
NP361hTert cells that were immortalized by hTert alone. The
rates of loss of EBV-infected NP550hTert and NP361hTert cells
after infection were monitored when the cells were passaged at 7,
14, and 21 days postinfection (DPI) with a splitting ratio of 1:3
(Fig. 4A). The percentage of EBV-infected cells in hTert-im-
mortalized NPE cell lines dropped rapidly at each passage (Fig.
4A). In our previous study (8) we had observed that the EBV-
infected NPE cells have a lower growth rate than uninfected cells.
The loss of EBV-infected cells may be a result of uninfected cells
outgrowing the EBV-infected cells during prolonged culture. We
proceeded to examine the effects of EBV infection on growth and
cellular senescence in hTert-immortalized NPE cells. The ex-
pression of p16 and p21 (markers for cell-cycle arrest) in EBV-
infected NP550hTert cells was examined at 14 DPI by immuno-
fluorescence staining (Fig. 4B). A higher percentage of EBV-
infected NP550hTert cells than of uninfected NP550hTert cells
expressed p16 and p21. To confirm further the up-regulation of
p16 in EBV-infected NP550hTert cells, the EBV-infected (GFP+)
and uninfected (GFP−) cells were separated by FACS and were
examined for p16 expression by immunostaining. Again,the EBV-
infected NP550hTert cells expressed a higher level of p16 (Fig.
4C). We then separated the EBV-infected cells from uninfected
cells by FACS at 3, 7, and 14 DPI and examined the percentage of
cells undergoing cellular senescence by senescence-associated
(SA)–β-galactosidase staining (an established biochemical marker
for cellular senescence) (Fig. 4D). In both cell lines, a significantly
higher percentage of cells expressed SA–β-galactosidase in the
EBV-infected populations than in uninfected populations (Fig.
4D). All these observations showed that growth arrest and cellular
senescence are common features of hTert-immortalized NPE cell
lines after infection by EBV and may explain their slower growth
rate compared with uninfected cells.
Overexpression of Cyclin D1 in NPE Cells Overrides Growth Inhibition
and Cellular Senescence Induced by EBV Infection. To see if over-
expression of cyclin D1 overrides the growth inhibition induced
by EBV infection, we separated EBV-infected and uninfected
cells (at 7 DPI) in both control and cyclin D1-overexpressing
NP550hTert cells by FACS and compared their growth rates
(Fig. 5A). The EBV-infected populations of the vector control
NP550hTert cells failed to proliferate up to day 14 after sorting,
whereas the NP550hTert cells overexpressing cyclin D1 contin-
ued to proliferate, albeit at a slower rate than uninfected cells
(Fig. 5A). Using SA–β-galactosidase staining, we also showed
that overexpression of cyclin D1 in NP550hTert cells suppressed
the cellular senescence induced by EBV infection. EBV-induced
cellular senescence is reduced almost fourfold in cells over-
expressing cyclin D1 as compared with control NP550hTert cells
(Fig. 5B). The EBV-infected NP550hTert cells overexpressing or
not overexpressing cyclin D1 were examined further for pro-
liferative potential by a BrdU incorporation assay. BrdU in-
corporation was 4.6-fold higher in EBV-infected NP550hTert
cells overexpressing cyclin D1 than in control NP550hTert cells
(Fig. 5C). Taken together, these observations strongly indicate
that overexpression of cyclin D1 suppresses EBV-induced growth
inhibition and cellular senescence in premalignant NPE cells.
Effects of Cyclin D1 Overexpression in Regulating Lytic and Latent
EBV Gene Expression in Immortalized NPE Cells. Overexpression of
cyclin D1 could suppress differentiation in immortalized NPE cells
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Fig. 2. Cells overexpressing cyclin D1 can resist dif-
ferentiation induced by serum treatment. (A) (Left)
Comparison of proliferation rates of control (infected
with an empty retroviral vector) and cyclin D1-over-
expressing NP550hTert and NP361hTert cells with or
without FBS treatment. (Right) Growth curves of the
control and CDK4R24C-overexpressing NP550hTert
cells treated with FBS. All the control cells eventually
lost their proliferative potential after FBS treatment.
The proliferative potentials after FBS treatment were
much less affected in NP550hTert and NP361hTert
cells overexpressing cyclin D1 than in control cells.
MeansandSDswerecalculatedfromtriplicatewellsof
two independent experiments. **P < 0.01; two-tailed
Student t test. (B) NP550hTert cells overexpressing
cyclin D1 expressed much lower levels of involucrin
(detected by immunofluorescence staining) than did
control cells. (C) Western blot analysis shows that
involucrin expression was induced in NP550hTert and
NP361hTert control cells upon treatmentwith FBS but
not in cyclin D1- or CDK4R24C-transduced NP361hTert
andNP550hTert cells. Akata cell lysatewasusedas the
negative control for involucrin detection. High cal-
cium content is known to induce robust differentia-
tion in hTert-immortalized epithelial cells. Cell lysate
of CaCl2-treated NP550hTert cells was included as
a positive control for involucrin detection. Primary
NP550 cells, which are highly responsive to FBS-in-
duced differentiation, were included as a positive
control for involucrin detection.
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(Fig. 2). Previous studies have suggested that cellular differen-
tiation could induce lytic reactivation of EBV (14, 15). Therefore,
we investigated the effect of overexpressing cyclin D1 on the
expression of lytic and latent genes of EBV by real-time PCR,
immunocytochemistry, and Western blotting analysis. Seven days
after infection, the EBV-infected control and cyclin D1-over-
expressing NP550hTert cells were live-sorted by FACS and
examined for transcript levels of lytic and latent genes. The
EBV-infected cells overexpressing cyclin D1 had higher levels of
mRNA transcripts of latent EBV genes (EBER1/2 and EBNA1)
but lower transcript levels of EBV lytic genes (BZLF1, BRLF1,
BMRF1, and BGLF4) than control NP550hTert cells (Fig. 6A).
We further examined the expression of EBV-encoded proteins
at the single-cell level using immunofluorescence staining. The
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Fig. 3. Activation of the cyclin D1 pathway enhanced clonal proliferation of EBV-infected cells. (A) Western blots confirming the exogenous expression of cyclin
D1 or CDK4R24C (a p16-insensitive CDK4 mutant) or knockdown of p16 by shRNA in hTert-immortalized NPE cells. After infection with EBV, the immortalized NPE
lines were sorted for GFP+ cells, were plated at a low cell density, and were inspected for the appearance of proliferative EBV-infected (GFP+) colonies 21 d after
sorting. Clonal proliferation was observed in all EBV-infected immortalized NPE cells overexpressing either cyclin D1 or CDK4R24 or after p16 expression was
knocked down but not in their control parental lines infected with an empty vector. The morphologies of proliferative EBV-infected colonies (GFP+) from im-
mortalized NPE cells expressing cyclin D1 or CDK4R24C or with p16 down-regulation are shown here. (B) Clonal proliferation of EBV-infected cells also was observed
in NPE cell lines immortalized by the combined action of hTert and either cyclin D1 or CDK4R24C but not in NPE cells immortalized by hTert alone. Phase-contrast
and fluorescent images show the formation of colonies in cell lines overexpressing cyclin D1 or CDK4R24C but not in cell lines immortalized by hTert alone.
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EBV-infected populations of both control and cyclin D1-over-
expressing cells were purified by FACS at 3, 7, and 14 DPI and
were examined for expression of LMP1, BZLF1, and viral capsid
antigen p18 (VCAp18) (Fig. 6B). Expression of LMP1 and BZLF1
was observed in only a small subset (3–6% at 3 DPI) of EBV-
infected cells (Fig. 6B). We did not observe a significant difference
in the percentage of LMP1-expressing cells between the con-
trol and cyclin D1-overexpressing NPE cells. The population of
BZLF1+ cells ranged from 4–6% and appeared to be lower in
cells overexpressing cyclin D1 than in control cells (Fig. 6B). The
number of cells expressing BZLF1 diminished progressively at
7 DPI and 14 DPI. Another lytic EBV protein, VCAp18, which is
expressed at a late stage of lytic replication, was barely detectable
in EBV-infected cells by immunocytochemistry (Fig. 6B).
Western blot analysis also was performed to compare the
protein levels of LMP1 and BZLF1 in various EBV-infected cell
lines. EBV-transformed B-cell lines, including Akata cells before
and after lytic activation, and a lymphoblastoid cell line (LCL)
were included as positive controls for detection of LMP1 and
BZLF1 expression by Western blotting (Fig. 6C). Cyclin D1 over-
expression in immortalized NPE cells apparently had a minimal
impact on levels of LMP1 expression but appeared to down-
regulate the expression of BZLF1 (Fig. 6C).
Western blot analysis revealed a gradual loss of LMP1 expres-
sion in the EBV-infected cells after several rounds of sorting for
GFP+, whereas BZLF1 expression rapidly diminished and became
undetectable after the first round of sorting (Fig. 6D). The Cp
promoter is involved in the transcription of EBNA3C and -3A in
EBV-infected B cells to bypass the G1/S checkpoint for main-
taining the growth of LCL (16). The Qp promoter usually is active
in latent EBV infection in epithelial cells. Using semiquantitative
RT-PCR, we examined the activity of both Cp and Qp in infected
cells. We confirmed that the Cp promoter was inactive during EBV
infection in epithelial cells, whereas Qp was substantially activated
in EBV-infected NPE cells, particularly at 100 DPI (Fig. 6E).
Establishment of Stably EBV-Infected Cell Lines. After subsequent
rounds of cell sorting by GFP fluorescence, stable EBV-infected
cell lines were established in NP550hTert and NP361hTert
cells overexpressing cyclin D1 (Table 1 and Fig. 7A and Fig.
S4). Both lines were passaged for more than 18 mo, and more
than 95% of cells retained the EBV genome (Fig. 7A and Fig. S4).
Varying copy numbers of the EBV genomes were detected in
the nuclei of EBV-infected cells, as demonstrated by FISH for
EBV genomes (Fig. 7B). The high copy number of EBV genomes
(the majority of cells contained 25–100 copies) (Fig. 7B) in the
stably infected cell lines implies that the cells have amplified
the episomal virus genome after infection. Most, if not all, the
hybridization signals were obtained on only one chromatid in
the paired-sister chromatids (Fig. 7B), indicating that the ma-
jority of EBV genomes in EBV-infected NPE cells were not
integrated into host chromosomes.
Similarly, stable EBV-infected lines were established by sorting
the EBV-infected cells from NPE cells immortalized by combined
action of hTert with either cyclin D1 or CDK4R24C (NP550-
CDK4R24C-hTert, NP361-CDK4R24C-hTert, NP446-cyclinD1-hTert,
and NP446- CDK4R24C-hTert) (Table 1 and Fig. S5) but not in
NPE cells immortalized by hTert alone, except for NP460hTert,
which harbors the p16 deletion. These cell lines were able to
retain more than 90% of EBV-infected cells over long period of
propagation (Fig. S5). Real-time PCR and Western blots were
performed to access various EBV-encoded genes in transcrip-
tional and protein levels (Fig. 7C and Fig. S6). The expression
levels of EBER1/2 were comparable among all the stably infec-
ted NPE cell lines and ranged from 0.2-fold to 0.8-fold that
of Akata cells (Fig. S6). However, the number of EBNA1 and
LMP1 transcripts was much lower in EBV-infected NPE cell
lines than in EBV-infected Akata cells (Fig. S6). Interestingly,
despite the low transcript level, EBNA1 protein levels in NPE cell
lines were comparable to levels in Akata cells, as shown in the
Western blot analysis (Fig. 7C). Western blots also showed that
the stably EBV-infected NPE cell lines expressed low levels of
LMP1 but not of BZLF1 (Fig. 7C).
Discussion
Cyclin D1 Expression Suppresses Growth Inhibition and Senescence
Caused by EBV Infection. The current hypothesis of NPC patho-
genesis is that infection of EBV in premalignant nasopharyngeal
lesions harboring genetic alterations facilitates and promotes
malignant transformation of NPE cells (3, 5, 7). We previously
reported that cyclin D1 overexpression is a common event in
NPC (10). In this study, we report that cyclin D1 overexpression
also is common in dysplastic NPE tissues and coexists with EBV
infection (Fig. 1). The close association of EBV infection and
overexpression of cyclin D1 prompted us to investigate if there
is a functional relationship between these two early events
in NPC pathogenesis. During differentiation, cyclin D1 activity
is inhibited, and cells exit the cell cycle. In contrast over-
expression of cyclin D1 promotes cell-cycle progression and
perturbs cellular differentiation (11, 13). A role of cyclin D1
in suppressing responses of immortalized NPE cells to serum-
induced differentiation was observed in this study (Fig. 2) and
may have implications for the close association of EBV infection
with undifferentiated NPC.
In this study, we observed that EBV-infected NPE cells im-
mortalized by hTert alone failed to propagate and were lost rapidly
upon serial passages (Figs. 3 and 4A). We attributed the rapid
loss of EBV-infected NPE cells to the induction of growth in-
hibition and cell senescence caused by EBV infection. Growth
inhibition of EBV-infected hTert-immortalized cells was associ-
ated with the expression of high levels of p16 and p21, positive
expression of SA–β-galactosidase, and lower rates of BrdU
incorporation (Figs. 4 and 5). The induction of growth arrest in
EBV-infected NPE cells may be a reason for the infrequent
detection of EBV in normal nasopharyngeal epithelium in vivo
(2). Additional factors may underlie the failure of EBV-infected
normal NPE cells to propagate in vivo. For example, EBV in-
fection per se may activate host immune-defense mechanisms to
Table 1. Immortalized NPE cell lines with dysregulated components in the cyclin D1 pathway support proliferation of EBV-infected
cells and their establishment in stable EBV-infected cell lines
Cell line
Dysregulated component in
cyclin D1 pathway
Appearance of proliferative
clones after EBV infection
Establishment of stable line
with EBV infection?
NP460htert p16 deletion yes yes
NP550hTert — No No
NP361hTert — No No
NP550hTert+cyclinD1 cyclinD1 overexpression yes yes
NP361hTert+cyclinD1 cyclinD1 overexpression yes yes
NP446-cyclinD1-hTert cyclinD1 overexpression yes yes
NP550-CDK4R24C -hTert CDK4R24C overexpression yes yes
NP361-CDK4R24C -hTert CDK4R24C overexpression yes yes
NP446-CDK4R24C -hTert CDK4R24C overexpression yes yes
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suppress the proliferation of infected cells through the induction
of type I interferons (17). It also is common for the invading virus
to shut down the host’s replication machinery to facilitate viral
DNA replication (18, 19). For example, infection by influenza A
virus, T-cell leukemia virus, and corona virus are all known to
arrest the infected host cells at the G0/G1 phase (20–22). Ex-
pression of EBV lytic genes, e.g., BGLF5, BZLF1, and BRLF1,
also can induce cell-cycle arrest in infected cells (19, 23, 24).
Importantly, we observed that overexpression of cyclin D1
in NPE cells can rescue the growth inhibition and senescence
phenotypes caused by EBV infection (Fig. 5). In this study, we
showed that immortalized NPE cell lines can be infected by EBV
at variable infection rates (Fig. S2). However, stably EBV-
infected NPE cell lines could be established only in immortalized
NPE cells overexpressing cyclin D1 or in NPE cells with dys-
regulated cyclin D1-related pathways by expressing the p16-
insensitive CDK4R24C or p16 silencing (Table 1). In addition,
we reported previously that stable EBV infection can be achieved
in a telomerase-immortalized NPE cell line, NP460hTert, har-
boring the p16 deletion (25). Furthermore, the p16 gene, which
is the key inhibitor of the cyclin D1/CDK4 activity, frequently is
deleted or inactivated by methylation in premalignant nasopha-
ryngeal epithelium before EBV infection (6, 26). We conclude
that overexpression of cyclin D1 or aberrant activation of the
cyclin D1 pathway may provide advantages supporting stable EBV
infection in premalignant NPE cells.
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Effects of Cyclin D1 on EBV Gene Expression in EBV-Infected NPE Cells.
We investigated the effects of cyclin D1 on the expression of
representative latent and lytic EBV genes using real-time PCR.
Up-regulation of EBNA1 and EBER1/2 was detected in EBV-
infected hTert-immortalized NPE cells overexpressing cyclin D1
as compared with control cells (Fig. 6A). A main function of
EBNA1 is to tether the EBV episome to the host chromosome to
ensure proper segregation of EBV genomes during mitosis (27).
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EBER expression has antiapoptotic and growth-stimulating
effects on EBV-infected cells (28). Enhanced expression of EBNA1
and EBER1/2 in cells overexpressing cyclin D1 may support stable
EBV infection in NPE cells. On the other hand, cyclin D1 appears
to suppress lytic EBV infection, because all the lytic genes exam-
ined, including BZLF1, BRLF1, BMRF1, and BGLF4, were gen-
erally down-regulated in EBV-infected NPE cells overexpressing
cyclin D1 (Fig. 6A). Previous reports have shown a close associa-
tion of epithelial differentiation and lytic EBV gene expression
(29, 30). The lytic promoter Zp, which is crucial in the initiation
of EBV lytic reactivation, contains a differentiation-responsive
element. Lytic gene expression could be detected in the upper
differentiated layers of the EBV-infected epithelial cell epider-
mis of oral hairy leukoplakia in immunosuppressed patients (31).
The suppressive effect of cyclin D1 on differentiation may sup-
press lytic reactivation of EBV in infected cells. However, acti-
vation of lytic replication of EBV may not be the main reason for
the loss of EBV-infected hTert-immortalized cells in our study.
Immunofluorescence staining reveals that only a small subset of
EBV-infected cells expressing BZLF1 (Fig. 6B) and an even
lower percentage of infected NPC cells (<1%) expressed the
viral capsid protein VCAp18 (Fig. 6B). BZLF1 was detectable in
only a small subpopulation of EBV-infected cells, making it
unlikely that loss of EBV+ cells in NPE cultures is a direct con-
sequence of differentiation-induced EBV reactivation. However,
the potential role of cyclin D1 in suppressing lytic replication of
EBV in NPE cells in vivo remains to be defined by further in-
vestigation. Nonetheless, BZLF1-expressing cells in vitro were
rapidly lost upon serial passages (Fig. 6D), suggesting that lytic
infection may not support EBV persistence. It has been sug-
gested that the expression of LMP1 contributes to the support of
persistent EBV infection in NPC (32, 33). However, Western
blot analysis indicated that cyclin D1 overexpression has minimal
effects on LMP1 expression in EBV-infected NPE cells (Fig. 6 B
and C). Besides, LMP1 is detectable in <5% of the cells in both
infected cultures, ruling out a major contribution of LMP1 to
enhancing clonal outgrowth of EBV-infected cells overexpressing
cyclin D1 (Fig. 6B). LMP1 expression also diminished in EBV-
infected cells upon serial passages (Fig. 6D).
We also confirmed that Cp is not activated in EBV-infected
NP550hTert cells but is active in LCL cells (Fig. 6E). This result
may explain why EBV can transform B cells into proliferative
LCL cells but induces growth arrest in NPE cells (34). EBV
infection in B cells initiates a growth/proliferative program. At
the initial phase of infection, the Wp promoter of EBV is acti-
vated to transcribe the EBNA2 gene, driving the infected B cell
to enter the cell cycle from the resting phase (G0) (16). EBNA2
also acts as a transcription factor that activates the viral Cp
promoter to transcribe other genes, including EBNA3C and -3A,
which have been shown to repress the expression of p16 and
p14 to facilitate cell-cycle progression and growth of LCL (35).
However, neither the Wp nor the Cp promoter is activated during
EBV infection in epithelial cells (36). Clearly, the cellular con-
tent of NPE cells is different from that of B cells and is not
permissive for the transcription of EBV genes, which are known
to override the cell-cycle checkpoints of infected host cells. Hence,
genetic alterations, such as overexpression of cyclin D1 and in-
activation of p16, which dampen the growth arrest and senescence
stimuli, may play an important role in facilitating the persistence
of EBV infection in NPE cells.
Several rounds of sorting of EBV-infected populations in cell
lines with deregulated cyclin D1 pathways led to the establishment
of stably EBV-infected cell lines (Table 1, Fig. 7A, and Figs. S4
and S5). We determined the EBV genome load in NP550hTert+
cyclinD1+EBV cells and NP361hTert+cyclinD1+EBV cells us-
ing in situ hybridization of fluorescent probes specific for EBV
DNA (Fig. 7B). The high copy number of EBV in both cell lines
suggests that the cells amplified the episomal virus genome after
infection (36). This amplification may contribute to the persistence
of EBV propagation. The examination of EBV gene expression
profile revealed that all the stably infected cell lines express
EBNA1, LMP1, LMP2A, and EBER1/2, as shown by Western
blots or real-time PCR (Fig. 7C and Fig. S6), indicating that
EBV infection manifested type II latency in these NPE cell lines,
resembling the expression pattern in NPC tumors.
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overexpressing cyclin D1 and in control cells. (A)
Overexpression of cyclin D1 suppressed the mRNA
transcription of lytic EBV genes in EBV-infected cells
but up-regulated the mRNA transcripts of EBNA1
and EBER1/2. Expression of individual EBV genes
was normalized to GAPDH expression. The basal ex-
pression levels of lytic and latent genes in the con-
trol NP550hTert cells (infected with empty vector)
are indicated as “1” for comparison with gene-
expression levels in the cells overexpressing cyclin
D1. (B) Expression of the EBV-encoded proteins in-
cluding LMP1, BZLF1, and VCAp18 was examined
in EBV-infected populations of control and cyclin
D1-overexpressing NP550hTert cells. Means and SDs
were calculated from triplicate wells. *P < 0.05 in
a two-tailed Student t test. (C) Western blot analysis
showing down-regulation of BZLF1 in cells over-
expressing cyclin D1 vs. vector control cells. LMP1
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Conclusion. In this study, we show that premalignant nasopha-
ryngeal epithelium commonly overexpresses cyclin D1 and is
closely associated with EBV infection. We further demonstrate
that overexpression of cyclin D1 can suppress differentiation.
EBV infection in NPE cells induces growth arrest and cellular se-
nescence that can be suppressed by the overexpression of cyclin
D1 or by dysregulation of the p16/CDK4 pathway. Over-
expression of cyclin D1 or CDK4R24C in immortalized NPE cells
supports stable EBV infection, leading to the establishment of
stable EBV-infected cell lines expressing latent EBV genes. Our
study provides evidence that preexisting genetic events, notably
cyclin D1 overexpression, and related molecular events support
the establishment of stable EBV infection in premalignant na-
sopharyngeal epithelium and play a role in NPC pathogenesis.
Materials and Methods
Please refer to SI Materials and Methods for detailed descriptions of ex-
perimental procedures and reagents used in this study. The immortalized
NPE cell lines were established and were maintained in a serum-free medium
with growth factor supplements. Expression of hTert, cyclin D1, or CDK4R24C
in primary NPE cells was achieved by retrovirus infection. Immortalized cell
lines with p16 knockdown were generated using lentiviral-mediated ex-
pression of shRNA.
The NPE cells were infected with EBV using a previously published protocol
(8). The detailed protocol of the EBV infection and the experimental proce-
dures of FACS analysis, live-cell sorting, SA–β-galactosidase assay, proliferation
and colony formation assays of EBV-infected cells, the BrdU incorporation
assay, and FISH are described in SI Materials and Methods.
Western blotting, immunofluorescence staining, real-time PCR, and
semiquantitative PCR were used to assess protein or gene expression in
EBV-infected cells. The probes or primers used in real-time PCR or PCR are
listed in Table S1. Detailed experimental procedures are described in SI
Materials and Methods.
In this study, H&E staining, cyclin D1 immunostaining, and EBER in situ hy-
bridization were performed on consecutive sections of six biopsies of dysplastic
nasopharyngeal tissue.
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